Daily Progress: Cardinal Health, Inc (CAH) Gain 0.08%, Closing at $207.54

Nora Barnes

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

In the latest session, Cardinal Health, Inc (NYSE: CAH) closed at $207.54 up 0.08% from its previous closing price of $207.37. In other words, the price has increased by $0.08 from its previous closing price. On the day, 0.7 million shares were traded. CAH stock price reached its highest trading level at $208.85 during the session, while it also had its lowest trading level at $207.27.

Ratios:

For a deeper understanding of Cardinal Health, Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.74 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.08. For the most recent quarter (mrq), Quick Ratio is recorded 0.52 and its Current Ratio is at 0.96.

Upgrades & Downgrades

In the most recent recommendation for this company, Barclays on December 09, 2025, initiated with a Overweight rating and assigned the stock a target price of $243.

On June 03, 2025, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight but kept the price unchanged to $179.

Jefferies Upgraded its Hold to Buy on February 05, 2025, whereas the target price for the stock was revised from $140 to $150.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 20 ’25 when WEITZMAN DEBORAH bought 21,367 shares for $150.53 per share.

WEITZMAN DEBORAH sold 21,367 shares of CAH for $3,216,375 on Aug 20 ’25. The CEO, PSS Segment now owns 53,428 shares after completing the transaction at $150.53 per share. On Aug 20 ’25, another insider, Hollar Jason M., who serves as the Chief Executive Officer of the company, sold 35,901 shares for $150.04 each. As a result, the insider received 5,386,566 and left with 200,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAH now has a Market Capitalization of 49310474240 and an Enterprise Value of 53897474048. As of this moment, Cardinal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 31.33, and their Forward P/E ratio for the next fiscal year is 18.71. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.26. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.21. Its current Enterprise Value per Revenue stands at 0.23 whereas that against EBITDA is 15.208.

Stock Price History:

The Beta on a monthly basis for CAH is 0.65, which has changed by 0.74198425 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, CAH has reached a high of $214.93, while it has fallen to a 52-week low of $117.53. The 50-Day Moving Average of the stock is 7.50%, while the 200-Day Moving Average is calculated to be 29.09%.

Shares Statistics:

For the past three months, CAH has traded an average of 2.51M shares per day and 2225090 over the past ten days. A total of 238.00M shares are outstanding, with a floating share count of 237.00M. Insiders hold about 0.25% of the company’s shares, while institutions hold 90.30% stake in the company. Shares short for CAH as of 1765756800 were 4904967 with a Short Ratio of 1.96, compared to 1763078400 on 8047562. Therefore, it implies a Short% of Shares Outstanding of 4904967 and a Short% of Float of 2.3800000000000003.

Dividends & Splits

According to the company, the forward annual dividend rate for CAH is 2.03, from 2.033 in the trailing year. Against a Trailing Annual Dividend Yield of 0.009803733. The stock’s 5-year Average Dividend Yield is 2.5. The current Payout Ratio is 31.43% for CAH, which recently paid a dividend on 2025-10-01 with an ex-dividend date of 2026-01-02. Stock splits for the company last occurred on 2001-04-23 when the company split stock in a 3:2 ratio.

Earnings Estimates

The dynamic stock of Cardinal Health, Inc (CAH) is currently being evaluated by a team of 15.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $2.69, with high estimates of $2.93 and low estimates of $2.52.

Analysts are recommending an EPS of between $10.18 and $9.74 for the fiscal current year, implying an average EPS of $9.83. EPS for the following year is $11.08, with 16.0 analysts recommending between $11.44 and $10.82.

Revenue Estimates

A total of 13 analysts believe the company’s revenue will be $64.88B this quarter.It ranges from a high estimate of $66.24B to a low estimate of $63.97B. As of. The current estimate, Cardinal Health, Inc’s year-ago sales were $55.26BFor the next quarter, 13 analysts are estimating revenue of $62.77B. There is a high estimate of $64.49B for the next quarter, whereas the lowest estimate is $60.67B.

A total of 14 analysts have provided revenue estimates for CAH’s current fiscal year. The highest revenue estimate was $263.87B, while the lowest revenue estimate was $255.37B, resulting in an average revenue estimate of $258.34B. In the same quarter a year ago, actual revenue was $222.58BBased on 14 analysts’ estimates, the company’s revenue will be $279.86B in the next fiscal year. The high estimate is $290.02B and the low estimate is $269.22B.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.